Merck Company, Inc. – Consensus Indicates Potential 17.0% Upside Merck Company, Inc. found using ticker (MRK) now have 20 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 125 and 85 calculating the average target price we see 100.85. Given that the stocks previous close was at 86.18 this would imply there is a potential upside of 17.0%. The day 50 moving average is 88.67 and the 200 day MA is 84.8. The company has a market capitalisation of $217,457m. Find out more information at: https:||www.merck.com [stock_market_widget type="chart" template="basic" color="green" assets="MRK" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $254,473m based on the market concensus. Merck Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines.